India Inc sheds debt to boost ratings, valuationsReliance Industries has reduced its gross debt by nearly Rs 1.21 lakh crore in FY21 to Rs 2.24 lakh crore, riding on a Rs 1.65 lakh crore a...
COVID-19 vaccine: Experts seek deep probe into adverse eventsA group of scientists and health experts are expected to write to Prime Minister Narendra Modi and health minister Harshvardhan, calling fo...
Bharat Bio trials went on despite adverse effect; experts worriedA participant in phase 1 clinical trials of the Covid vaccine being developed by Bharat Biotech in collaboration with Indian Council of Med...
US halt to plasma therapy brings a severe jolt to treatment plans in IndiaThe study on plasma therapy by the ICMR is still ongoing, and the results will be shared on completion of the study. The ambiguity, experts...
Health Ministry questioned on delayed use of Oxytocin after childbirthIn an article published in the reputed British Medical Journal (BMJ), doctors and maternal health experts have questioned the “scientific r...
Can clinical trials rebound in India? Upcoming rules, court case to set the road of recoveryThough Indian clinical-trial industry is ailing, it can get better. An ongoing court case and upcoming new rules will determine the arc of ...
- Government drafts official code of marketing practices for pharma industry
A draft Code of Marketing Practices for the Indian Pharmaceutical Industry, released on June 2, bans all kind of gifts to doctors.